Co-Authors
This is a "connection" page, showing publications co-authored by NATALIE VILLAFRANCO and NIDHY VARGHESE.
Connection Strength
1.626
-
An interdisciplinary consensus approach to pulmonary hypertension in developmental lung disease. Eur Respir J. 2024 Sep; 64(3).
Score: 0.244
-
Atrial septal defect closure is associated with improved clinical status in patients = 10?kg with bronchopulmonary dysplasia. Pulm Circ. 2023 Oct; 13(4):e12299.
Score: 0.228
-
Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration. Front Pediatr. 2023; 11:1275389.
Score: 0.226
-
Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration. Front Pediatr. 2023; 11:1050508.
Score: 0.219
-
Tracheostomy in Pulmonary Hypertension: Not for the Faint of Heart. Pediatr Crit Care Med. 2022 09 01; 23(9):754-756.
Score: 0.211
-
Pulmonary Hypertension in Children Part 1: Causes and Symptoms. Am J Respir Crit Care Med. 2021 11 15; 204(10):P17-P18.
Score: 0.200
-
Outcomes of COVID-19 infection in pediatric pulmonary hypertension: A single-center experience. Pediatr Pulmonol. 2021 12; 56(12):3960-3965.
Score: 0.197
-
Bronchopulmonary dysplasia - associated pulmonary hypertension: An updated review. Semin Perinatol. 2023 10; 47(6):151817.
Score: 0.057
-
Multiple mitochondrial dysfunctions syndrome 1: An unusual cause of developmental pulmonary hypertension. Am J Med Genet A. 2020 04; 182(4):755-761.
Score: 0.044